Adamis Pharmaceuticals | ADMP - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
Adma Biologics USD 87.63M 26.24M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Cara Therapeutics USD 20.65M 13.57M 2025-06
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Merck USD 18.17B 10.16B 2025-09
Pfizer USD 1.34B 295M 2025-09
RedHill Biopharma USD 2.87M 1.75M 2025-06